VBI Vaccines Statistics

Total Valuation

VBI Vaccines has a market cap or net worth of $17.06 million. The enterprise value is $55.18 million.

Market Cap	17.06M
Enterprise Value	55.18M

Important Dates

The next estimated earnings date is Monday, August 12, 2024, before market open.

Earnings Date	Aug 12, 2024
Ex-Dividend Date	n/a

Share Statistics

VBI Vaccines has 28.68 million shares outstanding. The number of shares has increased by 185.59% in one year.

Shares Outstanding	28.68M
Shares Change (YoY)	+185.59%
Shares Change (QoQ)	+57.87%
Owned by Insiders (%)	6.77%
Owned by Institutions (%)	13.03%
Float	26.73M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.81
Forward PS	0.92
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	5.86
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.34

Current Ratio	0.34
Quick Ratio	0.17
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.22

Financial Efficiency

Return on equity (ROE) is -1,094.90% and return on invested capital (ROIC) is -159.48%.

Return on Equity (ROE)	-1,094.90%
Return on Assets (ROA)	-95.60%
Return on Capital (ROIC)	-159.48%
Revenue Per Employee	$68,196
Profits Per Employee	-$608,623
Employee Count	138
Asset Turnover	0.11
Inventory Turnover	1.40

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.34% in the last 52 weeks. The beta is 2.17, so VBI Vaccines's price volatility has been higher than the market average.

Beta (5Y)	2.17
52-Week Price Change	-60.34%
50-Day Moving Average	0.65
200-Day Moving Average	0.62
Relative Strength Index (RSI)	35.46
Average Volume (20 Days)	175,843

Short Selling Information

The latest short interest is 416,988, so 1.45% of the outstanding shares have been sold short.

Short Interest	416,988
Short Previous Month	275,117
Short % of Shares Out	1.45%
Short % of Float	1.56%
Short Ratio (days to cover)	2.66

Income Statement

In the last 12 months, VBI Vaccines had revenue of $9.41 million and -$83.99 million in losses. Loss per share was -$5.65.

Revenue	9.41M
Gross Profit	-2.26M
Operating Income	-72.16M
Pretax Income	-82.99M
Net Income	-83.99M
EBITDA	-74.22M
EBIT	-76.20M
Loss Per Share	-$5.65

Full Income Statement

Balance Sheet

The company has $12.60 million in cash and $50.71 million in debt, giving a net cash position of -$38.12 million or -$1.33 per share.

Cash & Cash Equivalents	12.60M
Total Debt	50.71M
Net Cash	-38.12M
Net Cash Per Share	-$1.33
Equity (Book Value)	-5.47M
Book Value Per Share	-0.19
Working Capital	-51.23M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.00 million and capital expenditures -$484,000, giving a free cash flow of -$51.48 million.

Operating Cash Flow	-51.00M
Capital Expenditures	-484,000
Free Cash Flow	-51.48M
FCF Per Share	-$2.09

Full Cash Flow Statement

Margins

Gross margin is -24.06%, with operating and profit margins of -766.73% and -892.47%.

Gross Margin	-24.06%
Operating Margin	-766.73%
Pretax Margin	-881.79%
Profit Margin	-892.47%
EBITDA Margin	-788.65%
EBIT Margin	-809.64%
FCF Margin	-547.03%

Dividends & Yields

VBI Vaccines does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-185.59%
Shareholder Yield	-185.59%
Earnings Yield	-492.23%
FCF Yield	-301.71%

Dividend Details

Analyst Forecast

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on April 12, 2023. It was a reverse split with a ratio of 1:30.

Last Split Date	Apr 12, 2023
Split Type	Reverse
Split Ratio	1:30

Scores

VBI Vaccines has an Altman Z-Score of -15.04 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-15.04
Piotroski F-Score	4